SEQH Capital Research

SEQH Capital Research

ASP Isotopes (ASPI) Q3 2026: The Numbers Behind the 10-Q

11/17/26

SEQH Capital Research's avatar
SEQH Capital Research
Nov 17, 2026

ASP Isotopes (ASPI) Q3 2026: The Numbers Behind the 10-Q

Flat revenue, a $9.6M stock-comp quarter, and a much lighter balance sheet after the July note exchange. Full earnings model and analysis inside.


ASP Isotopes filed its Q3 2026 10-Q on November 16. We rebuilt the quarter line by line against Q2 2026 and Q3 2025, broke out all three segments, and built a five-quarter cash runway model. As always, this is research only. No ratings, no price targets, no recommendations.

The quarter at a glance

  • Revenue: $5.1M, flat on Q2 ($5.1M) and 4.0x Q3 2025 ($1.3M). Product revenue rose 13% QoQ; Q2’s $0.6M of collaboration revenue did not repeat.

  • Gross profit: $0.8M, down from $1.5M. Gross margin fell to 15.5% from 28.9%.

  • Loss from operations: $40.5M, 18% wider than Q2’s $34.2M.

  • Stock-based compensation: $9.6M, up from $4.5M in Q2. Operating expenses excluding SBC rose 2%.

  • Net loss: $30.9M, narrower than Q2’s $34.0M, but that includes an $11.25M non-cash gain on the July note exchange. Excluding the gain, the net loss was $42.1M.

  • Balance sheet: convertible notes at fair value fell to $85.9M from $203.4M after $109.2M of principal was exchanged for about 23.2M shares. Total liabilities fell $118.4M QoQ.

  • Cash: $201.7M unrestricted at September 30, plus $20.9M restricted. No short-term investments remain. Q3 operating cash use plus capex was $28.7M.

  • Debt: $53.0M total, $47.7M of it current. The DFC facility at Renergen is in default and the SBSA loan is in breach; both, along with the IDC loan, are classified current.

By segment (Q3 2026)

  • Specialist isotopes: revenue $4.3M (+10% QoQ), gross margin 38.2% (Q2 44.5%, Q1 50.0%), segment loss $18.6M.

  • Nuclear fuels: no revenue; segment loss $11.5M.

  • Helium & LNG: revenue $0.9M (+33% QoQ), gross margin -96%, segment loss $10.4M (Q2 $5.8M).

What’s in the full package (paid subscribers)

The live Excel model (11 tabs, every figure sourced to the 10-Qs):

  • Quarterly P&L for Q3 2025 and Q1 through Q3 2026, with QoQ, YoY and nine-month totals

  • Segment detail for all three segments: revenue, cost of sales, personnel, professional fees, other expenses and operating loss

  • Balance sheet across four quarter-ends, capital structure, the debt facility table and the note exchange

  • Quarterly cash flow plus the nine-month cash flow detail

  • A forecast through Q4 2027 under Low, Base and High scenarios, with yellow lever cells you can change: segment growth, gross margins, cash opex growth, cash conversion, capex, net interest and debt repayment

  • A checks tab that ties the P&L subtotals, segment totals and nine-month totals back to the reported figures

The 6-page PDF analysis:

  • Key points and a plain read of the quarter

  • Full results table against Q2 2026 and Q3 2025

  • Segment charts and commentary

  • Balance sheet, debt and share count changes

  • Cash flow and the nine-month cash bridge

  • Scenario runway: when unrestricted cash falls below a $50M buffer in each case

  • Dated items to track: the ENDRA/Renergen merger (4K Resources), first Si-28 and Yb-176 sales, the QLE listing plan and Virginia Gas Phase 2

Subscribe for free to continue reading

Enter your email and get every post from SEQH Capital Research.
Already have an account? Sign in
© 2026 SEQH Capital Partners · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.